Skip to main content
BLFS
NASDAQ Industrial Applications And Services

BioLife Solutions Issues Investor Presentation with Positive 2026 Revenue Growth Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$22.52
Mkt Cap
$1.088B
52W Low
$19.1
52W High
$29.62
52W Position info
18% above low
Off High info
24% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

BLFS sits 18% above its 52-week low of $19.1 on elevated volume (1.9× avg).

Summary

BioLife Solutions released an investor presentation outlining strong 2025 financial performance and providing positive revenue growth guidance of 17-20% for 2026, alongside an expectation of positive GAAP net income.


Key Events · Earnings and Guidance · BLFS

  • New 2026 Revenue Guidance

    The company forecasts 17-20% revenue growth for fiscal year 2026, building on its strong performance.

  • Positive GAAP Net Income Expected

    Management expects to achieve positive GAAP net income for the full fiscal year 2026, indicating continued operational improvement.

  • Reiterates Strong 2025 Performance

    The presentation highlights a 29% organic revenue growth and a 26% adjusted EBITDA margin for FY 2025, consistent with recent financial reports.

  • Strategic Portfolio Refocusing

    The company emphasized its successful portfolio refocusing, which has led to higher sustainable growth and improved profitability.


Analysis · BLFS · Industrial Applications And Services

This 8-K furnishes an investor presentation that provides key financial highlights and a positive outlook for 2026. Following strong 2025 results, the company projects 17-20% revenue growth for fiscal year 2026 and anticipates achieving positive GAAP net income for the full year. This guidance reinforces the company's growth trajectory and operational improvements, offering investors a clearer view of future performance.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BLFS was trading at $22.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $19.10 to $29.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BLFS - Latest Insights

BLFS
Sep 09, 2026, 5:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $34.95 info
Change: +$0.020 (+0.06%) info
Market Cap: $1.71B info
BLFS
Sep 09, 2026, 5:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $34.95 info
Change: +$0.020 (+0.06%) info
Market Cap: $1.71B info
BLFS
Sep 04, 2026, 5:23 PM EDT
Filing Type: DEFM14A
Importance Score:
8
Price at Filing: $35.25
Real-time Price: $34.95 info
Change: -$0.300 (-0.85%) info
Market Cap: $1.71B info
BLFS
Aug 06, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $33.93
Real-time Price: $34.95 info
Change: +$1.02 (+3%) info
Market Cap: $1.71B info
BLFS
Aug 06, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $33.93
Real-time Price: $34.95 info
Change: +$1.02 (+3%) info
Market Cap: $1.71B info